These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9827226)

  • 21. Modern histological classification of low grade B-cell lymphomas.
    Dogan A
    Best Pract Res Clin Haematol; 2005 Mar; 18(1):11-26. PubMed ID: 15694182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The problem of classifying lymphomas: an orderly prescription for progress.
    Berard CW; Hutchison RE
    Ann Oncol; 1997; 8 Suppl 2():3-9. PubMed ID: 9209632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution.
    Lee MY; Tan TD; Feng AC; Liu MC
    Am J Hematol; 2006 Aug; 81(8):568-75. PubMed ID: 16823825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Classification of T/NK-cell malignancies: Japanese perspective].
    Ohshima K
    Rinsho Ketsueki; 2010 Jul; 51(7):484-92. PubMed ID: 20693767
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical evaluation of classifications of malignant lymphoma from the viewpoint of history].
    Tobinai K
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2157-66. PubMed ID: 9881073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac involvement by malignant lymphoma: a clinicopathologic study of 25 autopsy cases based on the WHO classification.
    Chinen K; Izumo T
    Ann Hematol; 2005 Aug; 84(8):498-505. PubMed ID: 15782345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-Hodgkin lymphomas of mice.
    Hori M; Xiang S; Qi CF; Chattopadhyay SK; Fredrickson TN; Hartley JW; Kovalchuk AL; Bornkamm GW; Janz S; Copeland NG; Jenkins NA; Ward JM; Morse HC
    Blood Cells Mol Dis; 2001; 27(1):217-22. PubMed ID: 11358382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Malignant lymphoma-new entities in Asia].
    Yoshino T
    Rinsho Ketsueki; 2009 Aug; 50(8):622-9. PubMed ID: 19915377
    [No Abstract]   [Full Text] [Related]  

  • 29. [WHO and European Organization for Research and Treatment of Cancer (EORTC) classification of cutaneous lymphoma].
    Liu WP; Li GD
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):133-5. PubMed ID: 17493392
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral non-Hodgkin's lymphoma: review of the literature and World Health Organization classification with reference to 40 cases.
    Kemp S; Gallagher G; Kabani S; Noonan V; O'Hara C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Feb; 105(2):194-201. PubMed ID: 17604660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pathologist's view point. Part II --aggressive lymphomas.
    Pileri SA; Ascani S; Sabattini E; Fraternali-Orcioni G; Poggi S; Piccioli M; Piccaluga PP; Gamberi B; Zinzani PL; Leoncini L; Falini B
    Haematologica; 2000 Dec; 85(12):1308-21. PubMed ID: 11114138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemokine receptor repertoire reflects mature T-cell lymphoproliferative disorder clinical presentation.
    Moura J; Rodrigues J; Santos AH; Teixeira Mdos A; Queirós ML; Santos M; Gonçalves M; Fonseca S; Laranjeira C; Rodrigues AS; Correia Júnior E; Ribeiro F; Acosta MJ; Lima M
    Blood Cells Mol Dis; 2009; 42(1):57-63. PubMed ID: 18842429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The results of histological and immunohistological studies of primary biopsies in 400 patients with non-Hodgkin's lymphoma in the North-West region of Russia (according to WHO classification)].
    Krivolapov IuA
    Ter Arkh; 2004; 76(7):64-70. PubMed ID: 15379131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of local control in patients with non-Hodgkin's lymphoma according to the WHO classification.
    Sakata K; Satoh M; Someya M; Nagakura H; Oouchi A; Nakata K; Kogawa K; Koito K; Hareyama M; Himi T
    Strahlenther Onkol; 2005 Jun; 181(6):385-91. PubMed ID: 15925981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification.
    Kalyan K; Basu D; Soundararaghavan J
    Indian J Pathol Microbiol; 2006 Apr; 49(2):203-7. PubMed ID: 16933715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mature T- and NK cell neoplasms].
    Yamaguchi M
    Rinsho Ketsueki; 2009 Apr; 50(4):253-60. PubMed ID: 19404017
    [No Abstract]   [Full Text] [Related]  

  • 37. [Classification of malignant non-Hodgkin-lymphoma].
    Dörken B; Hunstein W
    Med Klin; 1979 Mar; 74(10):337-47. PubMed ID: 368545
    [No Abstract]   [Full Text] [Related]  

  • 38. Characteristics of 40 primary extranodal non-Hodgkin lymphomas of the oral cavity in perspective of the new WHO classification and the International Prognostic Index.
    van der Waal RI; Huijgens PC; van der Valk P; van der Waal I
    Int J Oral Maxillofac Surg; 2005 Jun; 34(4):391-5. PubMed ID: 16053848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The WHO (1997) classification of 370 cases of malignant lymphomas].
    He S; Zhang JB; Zhang JG; Yang SY; Han F
    Zhonghua Xue Ye Xue Za Zhi; 2003 Oct; 24(10):519-22. PubMed ID: 14690580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical investigations in T-cell and NK-cell non-Hodgkin lymphoma.
    Rosen S
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):9-10. PubMed ID: 18998260
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.